Kava is not considered an adaptogen. While it’s often grouped with stress-relief supplements like ashwagandha and rhodiola, kava works through a fundamentally different mechanism and doesn’t meet the established criteria that define adaptogens. It is classified as an anxiolytic, meaning it directly reduces anxiety symptoms rather than helping your body adapt to stress over time.
What Makes Something an Adaptogen
The term “adaptogen” was coined decades ago by the pharmacologist Brekhman, and it comes with specific requirements. A substance must meet three core criteria: it must be non-toxic at normal doses, it must produce a nonspecific resistance to multiple types of stress (physical, chemical, or biological), and it must have a normalizing effect on the body, helping restore balance regardless of what’s thrown off. More recent definitions add that any stimulating effect should be beneficial, not causing problems like insomnia or excessive energy expenditure.
The key idea is normalization. A true adaptogen acts like a thermostat for your stress response. If your stress hormones are too high, it helps bring them down. If your system is sluggish, it helps bring it up. It doesn’t push your body in one direction. It nudges it toward equilibrium.
How Kava Actually Works
Kava’s active compounds, called kavalactones, work primarily by enhancing the activity of GABA receptors in the brain. GABA is the nervous system’s main “calm down” signal. By amplifying it, kava reduces the release of excitatory neurotransmitters and limits the uptake of dopamine and norepinephrine. The result is sedation and anxiety relief, sometimes within a single dose.
This mechanism is strikingly similar to how benzodiazepines work. In fact, kava is used in some Western countries as a prescription-free alternative to benzodiazepines for stress-related anxiety and insomnia. It acts like a pause button for the nervous system: quick relief, but temporary. Once the kavalactones wear off, your baseline stress response hasn’t changed.
Compare this to ashwagandha, a widely recognized adaptogen. Ashwagandha targets the HPA axis, the hormonal command center that governs your stress response. Clinical studies have shown it can gradually reduce cortisol levels and improve sleep quality over weeks of use. Rather than overriding your nervous system in the moment, it recalibrates how your body responds to stress over time. That recalibration is exactly what the adaptogen label describes.
Where Kava Falls Short of Adaptogen Criteria
Kava fails the adaptogen test on multiple fronts. First, its effect is highly specific rather than nonspecific. It targets GABA receptors to reduce anxiety, but it doesn’t broadly strengthen resistance to physical, chemical, and biological stressors the way adaptogens are supposed to. You wouldn’t take kava to improve endurance or recover from illness.
Second, kava doesn’t normalize body functions. It pushes the nervous system in one direction: toward sedation. An adaptogen should help your body find balance without suppressing normal function. Kava’s sedative properties are its whole purpose, which is useful but categorically different from adaptogenic activity.
Third, and perhaps most disqualifying, kava has a meaningful toxicity concern. Adaptogens must be non-toxic and innocuous at recommended doses. In 2002, the FDA issued an advisory after kava-containing supplements were linked to severe liver injury, including hepatitis, cirrhosis, and liver failure, in over 25 reports from other countries. At least one case in the U.S. involved a previously healthy young woman who needed a liver transplant. Clinical review has confirmed that kava is potentially hepatotoxic, with risk factors including higher doses, prolonged use, and taking it alongside other medications or supplements. While poor raw material quality may also play a role, the liver risk is real enough that several countries have restricted or banned kava products at various points.
Kava’s Effectiveness for Anxiety
Understanding that kava isn’t an adaptogen doesn’t mean it’s useless. It has a long cultural history in Pacific Island communities, where kava drinks are used in religious rituals, social gatherings, and as a traditional medicine for relaxation and sleep. The question is how well it performs in controlled settings.
The clinical evidence is mixed. In the largest and best-designed study, 171 adults with generalized anxiety were randomly assigned to take either a placebo or 240 mg of kavalactones daily. After 16 weeks, anxiety scores dropped similarly in both groups. The kava group also reported poorer memory and more muscle tremors, and their liver enzymes increased, though no one in the study suffered acute liver injury.
Most supplement capsules contain 50 to 100 mg of kavalactones, with manufacturers generally recommending a maximum of 250 mg per day. Traditional kava consumption varies enormously, from 750 to over 8,000 mg of kavalactones daily, but traditional preparation (water-based extraction from fresh root) differs substantially from concentrated supplement extracts.
Kava vs. Ashwagandha for Stress
If you’re deciding between these two, the distinction matters. Kava is designed for acute anxiety relief. It calms you down now. Ashwagandha, as an adaptogen, is designed for gradual stress management over weeks. In one clinical trial, adults taking ashwagandha for eight weeks saw stress scores drop by 8 to 9 points on a 40-point scale, compared to 6 points for placebo. That’s a modest but measurable difference. However, another study of similar size found no advantage over placebo after 30 days, so ashwagandha’s evidence isn’t bulletproof either.
The practical takeaway: these supplements address different problems. Kava is closer to a sedative. Ashwagandha is closer to a long-term stress modulator. Neither is a substitute for the other, and neither has the kind of overwhelming clinical evidence that would make it a clear recommendation. If you’re drawn to kava specifically because you saw it listed alongside adaptogens, know that the grouping is a marketing convenience, not a pharmacological reality.